A bio firm listed on the KOSDAQ exchange is set to undergo a review due to unfaithful disclosure practices. This action highlights regulatory scrutiny over corporate transparency in South Korea's stock market.
AI-powered video analytics company Intellivix announced its intention to seek a Kosdaq listing this month, driven by record revenue, operating profit, and net profit achieved in 2025.
South Korean fintech firm Hanpass, specializing in overseas remittances, is set to debut on the Kosdaq this month with ambitions to become a global cross-border 'super app'.
The Kospi plunged 8 per cent on Wednesday (Mar 4), extending a steep selloff from the previous day as the escalating war in the Middle East rattled investor sentiment.
TeraView, a UK-based semiconductor equipment company specializing in terahertz technology, plans to list on South Korea's KOSDAQ market to target the Asian market and achieve a proper valuation. The company counts Samsung, Intel, and Nvidia among its clients.
Sam Chun Dang Pharm, a little-known drugmaker, has become a heavyweight on Korea’s Kosdaq, with its shares surging due to investor excitement over its pipeline of next-generation drugs, including oral insulin and a weight-loss pill.
Cha Biotech announced its decision to transfer 8.95 million shares in Cha Vaccine Institute, valued at 23.8 billion won ($15.8 million), to Solux, AriBio Investment Purpose No. 13, and other investors, reducing its stake in the Kosdaq-listed company.
Autonomous A2Z said Thursday it has completed a 40.5 billion won ($27.4 million) pre-IPO funding round, bringing its total funding to 122.5 billion won — the largest amount raised by a self-driving startup in Korea. The funding comes ahead of the company’s planned initial public offering later this year at the nation’s tech-heavy Kosdaq. It will support expansion of autonomous mobility projects at home and abroad, as well as investment in infrastructure and talent to advance end-to-end AI-based
While high-profile Korean startups such as Toss and Yanolja chase Wall Street valuations — following Coupang’s US listing — a British chip-equipment maker is betting on Seoul instead. TeraView, a UK firm that commercialized terahertz technology for ultraprecision semiconductor inspection, chose to list on Kosdaq rather than in London or New York. The company counts Samsung Electronics, Intel and Nvidia among its customers, supplying critical components used in advanced chip manufacturing. “TeraV
Hanpass, a South Korean fintech firm specializing in overseas remittances, saw its stock surge on the tech-heavy Kosdaq upon its market debut, signaling potential for global expansion.
South Korea's financial regulator said Wednesday that it will move to ban "split listing" by conglomerates here, which have long been blamed for hurting shareholder value, and create a two-tier system for the tech-laden Kosdaq market. The Financial Services Commission (FSC) said it would seek to ban duplicate listing, which occurs when a core business division is spun off and listed separately, a practice that has been frequently favored by large business groups here and cited as one of the majo
Mirae Asset Global Investments said Thursday that its TIGER Kosdaq150 ETF had surpassed 2 trillion won ($1.5 billion) in net assets, buoyed by strong market performance and renewed policy momentum surrounding the Kosdaq market. According to the Korea Exchange, the ETF’s net assets stood at 2.29 trillion won as of Wednesday’s close. The fund has added 1.96 trillion won so far this year, expanding its size nearly sevenfold. The ETF posted a 36.15 percent return during the same period, while retail